RwHealth, the leading provider of artificial intelligence (AI) to the healthcare industry, has reported 160% year-on-year growth as its data-led solutions are increasingly embraced by NHS trusts, private healthcare providers, and pharmaceutical companies.
Founded in 2017, RwHealth is headquartered in London's Canary Wharf. It works with more than 70 UK and international providers, and its AI technology has processed more than 10 million UK patients and 5.5 million across the Middle East and Australia.
How does the company use AI?
The company’s Data Science Platform combines AI and machine learning to give healthcare providers in-depth data to make better decisions and improve patient outcomes.
Being able to model patient numbers has been vital during Covid, and the RwHealth platform has helped UK hospitals to anticipate demand, combat bed shortages, and tackle worsening waiting list issues.
RwHealth's success mirrors the wider growth of AI in healthcare, as stakeholders across the health ecosystem find new ways to increase efficiency, save money, and deliver optimised clinical outcomes. In September 2020, NHSX, the organisation driving digital transformation in health and social care, announced a £250m investment into AI in UK healthcare.
Orlando Agrippa, CEO, and Founder of RwHealth, said: "We've grown at an extraordinary rate, as healthcare providers realise how AI can improve patient outcomes while helping to ease the wider pressures that the healthcare industry faces. It's important to tackle backlogs and bed capacity issues so that healthcare remains safe and steady as we attempt to recover post-Covid."
The acceleration of AI in healthcare
The rise of data in healthcare means that artificial intelligence (AI) has the potential to help transform the industry.
AI is now one of the top priorities for healthcare decision-makers, governments, investors, and innovators. An increasing number of governments have set out aspirations for AI in healthcare, such as Finland, Germany, the United Kingdom, Israel, China, and the United States. The private sector continues to play a significant role, with venture capital (VC) funding for the top 50 firms in healthcare-related AI reaching $8.5 billion, and big tech firms, startups, pharmaceutical and medical-devices firms and health insurers, all engaging with the nascent AI healthcare ecosystem.
The UK has the second-highest number of AI-driven healthcare technologies in development globally after the US, according to NIHR Innovation Observatory’s Mapping the Global Activity of AI Health Technologies, 2021.